OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Northeast GI Oncology Congress 2026: Two Days of Science, Debate, and New Perspectives in GI Cancer Care

Taofeek K. Owonikoko Named Candidate for ASCO President-Elect

Merck's Sacituzumab Tirumotecan Improves Survival in Advanced Gastroesophageal Cancer in Phase 3 TroFuse Trial

Verismo Therapeutics Licenses Stanford Technology for In Vivo CAR T Therapy

ECO Calls on EU Governments to Protect Cancer Care During Crises

Pumitamig Plus Nab-Paclitaxel Achieves 73.8% Response Rate in First-Line Advanced Triple-Negative Breast Cancer

Pelotonia Raises Record $31.1 Million in 2026, Bringing Total Cancer Research Funding Beyond $370 Million

Radiotherapy

OncoDaily RT is the dedicated radiation oncology platform of OncoDaily, focused on the rapidly evolving field of radiotherapy and cancer treatment. It covers clinical research, treatment advances, technology, education, and global collaboration, including precision radiotherapy, stereotactic radiotherapy, brachytherapy, adaptive radiotherapy, proton therapy, artificial intelligence, treatment toxicity, survivorship, patient-centered care, and integration with systemic treatments. Through OncoDaily RT, radiation oncologists, medical physicists, researchers, trainees, industry partners, and multidisciplinary cancer care professionals can follow the latest research, emerging technologies, treatment innovations, congress updates, expert perspectives, interviews, articles, social media coverage, and expert-led discussions, while sharing knowledge and advancing radiation oncology worldwide.